Navigation Links
Frost & Sullivan: Multi-Modality Breast Imaging Systems Spur Innovations in Europe
Date:8/26/2014

LONDON, Aug. 26, 2014 /PRNewswire/ -- National population-based screening programs for asymptomatic women aged 40 and above have been established in many European countries for early detection of breast cancer. With every passing year, this population cohort is expanding, spurring breast cancer screening rates and fuelling the need for breast imaging systems. With the number of women being diagnosed with breast cancer also bound to increase, the adoption of equipment for procedures such as biopsy and image guidance too will grow.

Logo - http://photos.prnewswire.com/prnh/20140826/139581

New analysis from Frost & Sullivan, Analysis of the European Breast Imaging Systems Market, finds that the market earned revenues of $988.3 million in 2013 and estimates this to reach $1,384.2 million in 2020. The study covers x-ray mammography, breast ultrasound, breast magnetic resonance imaging (MRI), molecular breast imaging (MBI), and breast computer-aided detection (CAD).

While mammography has been considered the 'gold standard' for breast screening, adjunct technologies such as breast ultrasound, breast MRI and MBI too are gaining traction as they improve the standards of diagnosis and treatment of breast cancers.

"The European market will continue to evolve as breast imaging systems vendors look for innovative technologies to battle the increasing rate of false positives and overcome limitations while scanning women with dense breast tissue," said Frost & Sullivan Healthcare Research Analyst Raghuraman Madanagopal. "3-D tomosynthesis, automated breast ultrasound and MBI are the results of such technological innovations that ensure maximum efficiency and minimum error rates."

However, sporadic reimbursement trends across countries may lead to equally sporadic uptake of these advanced modalities for breast imaging. While the more commonly performed mammography and the less expensive ultrasound procedures are reimbursed sufficiently, the trend changes for costly procedures such as MRI and MBI.

To overcome this restraint, many breast imaging facilities in Europe are employing multi-modality screening. This, in turn, is expected to drive the use of supplementary modalities such as breast ultrasound.

"Research studies in recent years have validated the benefits that multi-modality screening provides over regular mammography screening, since one modality can overcome the limitations of another," noted Madanagopal. "In accordance with this validation that a multi-modality approach improves the efficiency, specificity and sensitivity of breast cancer screening procedures, a wide product portfolio will be a core competitive factor in the European breast imaging systems market."

If you are interested in more information on this study, please email Anna Zanchi, Corporate Communications, at anna.zanchi@frost.com

Analysis of the European Breast Imaging Systems Market is part of the Advanced Medical Technologies Growth Partnership Service program. Frost & Sullivan's related studies include: US Nuclear Medicine and PET Imaging Systems Market, and European Ultrasound Market. All studies included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact
Anna Zanchi
Corporate Communications – Europe
P: +39.02.4851 6133
E: anna.zanchi@frost.com

http://www.frost.com 


'/>"/>
SOURCE Frost & Sullivan
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan: Healthcare Investor Focus on Malaysia Grows, Bolstered by Government Support and Medical Tourism
2. Frost & Sullivan Recognizes Baxano Surgical as a Leader in MIS Spine Innovation
3. Frost & Sullivan Honors Vitro Biopharma for its Outstanding Technological Innovations and Business Strategy in the Stem Cell Tools Industry
4. Frost & Sullivan Applauds F Cubed for its Game-Changing MRSA Screener, the NESDEP IU
5. Frost & Sullivan Honors Mobius Imaging for Developing a Mobile 32-Slice CT Scanner, the Airo Mobile Intraoperative CT
6. Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market
7. Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform
8. Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging
9. Frost & Sullivan Finds Wellness and Early Intervention Technologies Core Components in Healthcare Delivery Transformation
10. Frost & Sullivan Acknowledges Nanomades Unique Technology that Combines Multipoint Touch and Force Sensing on a Fully Flexible Substrate
11. Microlife Wins Accolades from Frost & Sullivan for its Unique Automated Oscillometric Blood Pressure Monitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):